Welcome, sign in or click here to subscribe.
Login: Password:




Email to a friend   Print   Comment   Reprints   Add to myDJC   Adjust font size

February 18, 2010


Richland-based IsoRay hired William Cavanagh as vice president of research and development for IsoRay Medical. Cavanagh was chief scientific officer for Sangretech Biomedical for six years, overseeing design and use of a novel cancer therapy. IsoRay is a medical isotope company focusing on the treatment of prostate cancer and other malignant diseases.